Cardiac Vagal Neurostimulation for Ventricular Rate Control During Atrial Fibrillation
Youhua Zhang, M.D., Ph.D.
, and Todor N. Mazgalev, Ph.D.
Dr. Zhang is Project Staff and Dr. Mazgalev is Full Staff, Department of Molecular Cardiology and Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.
Within the past 12 months, Dr. Zhang and Dr. Mazgalev report no commercial conflicts of interest.
The work described in this Cyberounds® has been supported in part by a grant from the State of Ohio to the Cleveland Clinic Atrial Fibrillation Innovation Center (AFIC), a Wright Center of Innovation.
Albert Einstein College of Medicine, CCME staff and interMDnet staff have nothing to disclose.
Estimated time to complete:
Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Albert Einstein College of Medicine is accredited
by the Accreditation Council for Continuing
Medical Education to provide continuing medical
education for physicians.
Upon completion of this Cyberounds®
, you should be able to:
- Discuss the current status of efforts to control the atrial fibrillation epidemic
- Describe the rhythm versus rate control approaches
- Discuss the intracardiac autonomic nervous system, and specifically the selective vagal control of atrioventricular nodal conduction.
- Discuss state-of-the-art new technologies utilizing implantable neural electrostimulators to achieve selective modulation of the intracardiac autonomic nervous system in order to control AV conduction and ventricular rate during atrial fibrillation.
- Assess critically different therapeutic options, including the latest application of implantable neural electrostimulators.